5-EPIFAT trial protocol: a multi-center, randomized, placebo-controlled trial of the efficacy of pharmacotherapy for fatigue using methylphenidate, bupropion, ginseng, and amantadine in advanced cancer patients on active treatment
Cancer-related fatigue (CRF) is still undertreated in most patients, as evidence for pharmacological treatments is limited and conflicting. Also, the efficacy of the pharmacological agents relative to each oth... (Source: Trials)
Source: Trials - April 3, 2024 Category: General Medicine Authors: Mojtaba Miladinia, Mina Jahangiri, Sharon Jackson White, Hossein Karimpourian, Alessandro Inno, Sally Wai-Chi Chan, Reza Ganji, Mahmood Maniati, Kourosh Zarea, Marziyeh Ghalamkari, Ali Farahat and Cecilia Fagerstr öm Tags: Study protocol Source Type: research

Patient with Asperger's Syndrome, with episodes of fantasizing and rocking of body, treated with aripiprazole - a case report
Psychiatr Pol. 2023 Dec 31;57(6):1135-1142. doi: 10.12740/PP/152316. Epub 2023 Dec 31.ABSTRACTIn this article, we present the case of an adult patient, whose main problem is episodes of fantasizing and rocking lasting up to 12 hours a day and completely preventing school development. The nature of the disorder in the patient is related to the sinking into fantasies, and not typical obsessions as in OCD. The patient was previously treated with drugs from the SSRI group, neuroleptics (without aripiprazole) and methylphenidate. Only methylphenidate showed some improvement; however, it made the patient feel ‟stiff in thinkin...
Source: Psychiatria Polska - April 2, 2024 Category: Psychiatry Authors: Maciej Dul Krzysztof Walczewski Source Type: research

Attention deficit and hyperactivity disorder and use of psychostimulants in Aotearoa, New Zealand: exploring the treatment gap
Discussion The data suggest failure of our health system to provide reasonable health care for a significant number of people with ADHD, and results in inequity in outcomes. New approaches are needed that will increase access to first-line medication, yet maintain appropriateness of diagnosis and limit risk of medication diversion.PMID:38546775 | DOI:10.1071/HC23126 (Source: Journal of Primary Health Care)
Source: Journal of Primary Health Care - March 28, 2024 Category: Primary Care Authors: Steven Lillis Source Type: research

Attention deficit and hyperactivity disorder and use of psychostimulants in Aotearoa, New Zealand: exploring the treatment gap
Discussion The data suggest failure of our health system to provide reasonable health care for a significant number of people with ADHD, and results in inequity in outcomes. New approaches are needed that will increase access to first-line medication, yet maintain appropriateness of diagnosis and limit risk of medication diversion.PMID:38546775 | DOI:10.1071/HC23126 (Source: Primary Care)
Source: Primary Care - March 28, 2024 Category: Primary Care Authors: Steven Lillis Source Type: research

Attention deficit and hyperactivity disorder and use of psychostimulants in Aotearoa, New Zealand: exploring the treatment gap
Discussion The data suggest failure of our health system to provide reasonable health care for a significant number of people with ADHD, and results in inequity in outcomes. New approaches are needed that will increase access to first-line medication, yet maintain appropriateness of diagnosis and limit risk of medication diversion.PMID:38546775 | DOI:10.1071/HC23126 (Source: Journal of Primary Health Care)
Source: Journal of Primary Health Care - March 28, 2024 Category: Primary Care Authors: Steven Lillis Source Type: research